Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe and Fenofibrate Coadministration in Mixed Hyperlipidemia
NCT00092560Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2002
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ezetimibe in mixed hyperlipidemia, sponsored by Organon & Co.. Started Dec 2002; status: completed.
02
Drugs
ezetimibe
03
Conditions
mixed hyperlipidemia
Beyond the preview
Go deeper on NCT00092560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092560.